THE TRANSPORT OF ACIDIC AMINO-ACIDS AND THEIR ANALOGS ACROSS MONOLAYERS OF HUMAN INTESTINAL ABSORPTIVE (CACO-2) CELLS IN-VITRO

被引:29
作者
NICKLIN, PL
IRWIN, WJ
HASSAN, IF
MACKAY, M
DIXON, HBF
机构
[1] UNIV ASTON,INST PHARMACEUT SCI,DRUG DEV RES GRP,BIRMINGHAM B4 7ET,W MIDLANDS,ENGLAND
[2] CIBA GEIGY PHARMACEUT CORP,HORSHAM RH12 4AB,W SUSSEX,ENGLAND
[3] UNIV CAMBRIDGE,DEPT BIOCHEM,CAMBRIDGE CB2 1QW,ENGLAND
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1995年 / 1269卷 / 02期
关键词
AMINO ACID; ARSONO COMPOUND; CACO-2; CELL; CARRIER-MEDIATED TRANSPORT; PH AND SODIUM DEPENDENCE; STRUCTURE-ACTIVITY RELATIONSHIP;
D O I
10.1016/0167-4889(95)00118-C
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The X(AG)(-) system, a sodium-dependent, acidic amino-acid transport system has been implicated in the transport of L-aspartate and L-glutamate across monolayers of human Caco-2 cells, an in vitro model of intestinal absorption. This system, which shares many properties with the L-glutamate carrier present in the human jejunum, is highly saturable (> 95% at 50 mu M), vectorial (apical-to-basolateral much greater than basolateral-to-apical) and sodium-, pH- and temperature-dependent. L-Aspartate was also transported against a 10-fold reverse concentration gradient, These data are consistent with a major (saturable) carrier-mediated pathway superimposed onto a minor non-saturable (diffusional) pathway, The carrier has an absolute sodium-dependence and the Michaelis constants for the sodium-dependent transport component (K-m) for L-aspartate and L-glutamate were 56 +/- 3 mu M and 65 +/- 6 mu M, respectively. Cross-inhibition studies showed that strong interaction with the carrier was limited to close analogues of the natural substrates. Potent inhibitors included L-aspartate, D-aspartate(K-i, 70 mu M), L-glutamate (K-i, 180 mu M) and threo-beta-hydroxy-DL-aspartate (K-i, 55 mu M), while partial inhibitors included alpha-methyl-DL-aspartate, D-glutamate, L-asparagine, L-proline and L-alanine. Replacement of the side-chain -COO- group (aspartate) with -SO3- (L-cysteate, K-i, 65 mu M) or -(H)P(OO- (DL-3-(hydroxyphosphoryl)alanine, K-i, 60 mu M) maintained strong interaction with the carrier while -As(O)(OHO- (DL-3-arsonoalanine, K-i, 1100 mu M) and -P(O)(OHO- (DL-3-phosphonoalanine, K-i 3270 mu M) were much more weakly bound, with the larger, but probably less ionised, arsono analogue being more tightly bound than the phosphono compound. The corresponding analogues of glutamate (homologous extension of the methylene chain) showed negligible interaction, We conclude that Caco-2 monolayers are a relevant experimental model for the study of the transport of acidic amino acids and their analogues in man.
引用
收藏
页码:176 / 186
页数:11
相关论文
共 42 条
[31]  
RABITO CA, 1983, J BIOL CHEM, V258, P2543
[32]   TRANSPORT OF ACIDIC AMINO-ACIDS BY HUMAN JEJUNAL BRUSH-BORDER MEMBRANE-VESICLES [J].
RAJENDRAN, VM ;
HARIG, JM ;
ADAMS, MB ;
RAMASWAMY, K .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (01) :G33-G39
[33]  
RAMASWAMY K, 1970, INDIAN J BIOCHEM, V7, P50
[34]   ACTIVE HEXOSE-TRANSPORT ACROSS CULTURED HUMAN CACO-2 CELLS - CHARACTERIZATION AND INFLUENCE OF CULTURE CONDITIONS [J].
RILEY, SA ;
WARHURST, G ;
CROWE, PT ;
TURNBERG, LA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1066 (02) :175-182
[35]   KINETICS OF THE SODIUM-DEPENDENT GLUTAMINE TRANSPORTER IN HUMAN INTESTINAL-CELL CONFLUENT MONOLAYERS [J].
SOUBA, WW ;
PAN, M ;
STEVENS, BR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 188 (02) :746-753
[36]  
TAKADA Y, 1991, CANCER CHEMOTHER PHA, V52, P89
[37]   DICARBOXYLIC AMINOACIDURIA - INBORN ERROR OF GLUTAMATE AND ASPARTATE TRANSPORT WITH METABOLIC IMPLICATIONS, IN COMBINATION WITH A HYPERPROLINEMIA [J].
TEIJEMA, HL ;
VANGELDE.HH ;
GIESBERTS, MA ;
SERENA, M ;
ANGULO, LLD .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1974, 23 (02) :115-123
[38]  
Trier J S, 1980, Methods Cell Biol, V21B, P365
[39]  
VINCENT ML, 1985, HUM NUTR-CLIN NUTR, V39C, P355
[40]   DRUG-DELIVERY VIA ACTIVE-TRANSPORT AT THE BLOOD-BRAIN-BARRIER - AFFINITY OF A PRODRUG OF PHOSPHONOFORMATE FOR THE LARGE AMINO-ACID TRANSPORTER [J].
WALKER, I ;
NICHOLLS, D ;
IRWIN, WJ ;
FREEMAN, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 104 (02) :157-167